Gaprin Market

Gaprin is a full-fledged microbiological protein, which is a biomass of inactivated cells of non-pathogenic methanotrophic bacteria and is intended for use as the main functional component of compound feeds and protein-vitamin supplements (BVD). Thanks to it, it is possible to produce complete, balanced compound feeds that ensure the intensive development of animal husbandry, poultry and fish farming. Gaprin contains: crude protein 70-79%. According to its composition, gaprin is a complete protein product with a high content of B vitamins (especially B12), amino acids and microelements, which fully meets the needs of animals of various groups and ages. In addition, in comparison with protein feeds of plant origin (including cereals and legumes, including soybeans), gaprin provides balanced amino acid nutrition for animals, primarily in terms of lysine, serine and methionine. Gaprin was produced from 1985 to 1994 at a pilot plant at the Svetlo-Yarsk BVK plant in the Volgograd region of CIS. Of the 40 thousand tons of haprin produced during the specified period, most of it was exported. However, in 1994 this production was closed. The bioprotein gaprin can also be produced from associated petroleum gas (APG), which is still flared in refineries and oil fields, including offshore oil platforms, as well as from methane from mines, coal seams and from methane biogas from waste processing.
Gaprin Market contains market size and forecasts of Gaprin in global, including the following market information:
Global Gaprin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gaprin Market Sales, 2017-2022, 2023-2028, (K Ton)
Global top five Gaprin companies in 2021 (%)
The global Gaprin market was valued at 288.1 million in 2021 and is projected to reach US$ 3372 million by 2028, at a CAGR of 42.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Food Grade Gaprin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gaprin include Unibio, Calysta, Prtotelux, Metanica and Giprobiosyntez, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gaprin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gaprin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Ton)
Global Gaprin Market Segment Percentages, by Type, 2021 (%)
Food Grade Gaprin
Feed Grade Gaprin
Global Gaprin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Ton)
Global Gaprin Market Segment Percentages, by Application, 2021 (%)
Food & Beverages
Animal Feed
Others
Global Gaprin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Ton)
Global Gaprin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gaprin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gaprin revenues share in global market, 2021 (%)
Key companies Gaprin sales in global market, 2017-2022 (Estimated), (K Ton)
Key companies Gaprin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Unibio
Calysta
Prtotelux
Metanica
Giprobiosyntez